Obtaining retatrutide outside of a regulated trial for example, through online grey-market suppliers carries significant legal and safety risks, as product quality, purity, and dosing accuracy cannot be guaranteed
Nausea and vomiting (common when starting the medication but usually temporary) Diarrhea or constipation Mild fatigue or dizziness Loss of muscle mass if weight loss is too rapid A study published in JAMA found that GLP-1s significantly reduce body weight and A1C levels (a marker of blood sugar control) in older adults
In a randomized clinical trial, tesamorelin reduced visceral adipose tissue and liver fat in HIV-infected patients (Stanley et al., JAMA, 2014), and its Phase 3 program (Falutz et al.) established the visceral-fat effect that underpins its FDA approval
It contributes to the use of fats as the preferred fuel for muscles and reduces the production of lactic acid
The efficacy of GLP-1 agonists in the treatment of obesity, particularly in individuals with type 2 diabetes, has been highlighted in large-scale clinical trials
If you've been turned down for a GLP-1 medication, you're not alonemany people face barriers when trying to get these prescriptions